dronabinol (synthetic THC in sesame oil)
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:dronabinol
|
| gptkbp:approvalYear |
1985
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A04AD10
|
| gptkbp:brand |
gptkb:Marinol
|
| gptkbp:chemicalClass |
Cannabis
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_III_(US)
|
| gptkbp:form |
sesame oil
|
| https://www.w3.org/2000/01/rdf-schema#label |
dronabinol (synthetic THC in sesame oil)
|
| gptkbp:indication |
chemotherapy-induced nausea and vomiting
anorexia associated with weight loss in AIDS patients |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
CB1 receptor agonist
CB2 receptor agonist |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
paranoia drowsiness euphoria dry mouth |
| gptkbp:bfsParent |
gptkb:Schedule_III_controlled_substances
|
| gptkbp:bfsLayer |
7
|